A dramatic, objective antiandrogen withdrawal response: Case report and review of the literature

Yiu Keung Lau, Manpreet K. Chadha, Alan Litwin, Donald L. Trump

Research output: Contribution to journalReview article

5 Scopus citations


Antiandrogen withdrawal response is an increasingly recognized entity in patients with metastatic prostate cancer. To our knowledge, there have been no reports describing a durable radiologic improvement along with prostate-specific antigen (PSA) with discontinuation of the antiandrogen agent bicalutamide. We report a case in which a dramatic decline of serum PSA levels associated with a dramatic improvement in radiologic disease was achieved with bicalutamide discontinuation.

Original languageEnglish (US)
Article number21
JournalJournal of Hematology and Oncology
Issue number1
Publication statusPublished - Dec 1 2008


All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Hematology
  • Oncology
  • Cancer Research

Cite this